Still’s Disease Treatment Market to Reach a Market Share Size Trends 2027

1. STILL’S DISEASE TREATMENT MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Still’s Disease Treatment Market - Overview Global Still’s Disease Treatment Market, by Treatment (Pain Management, Corticosteroids, Tocilizumab, Canakinumab, Anakinra, and Others), by Route of Administration (Injectable and Oral), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$1,539.4 million in 2020 and is expected to exhibit a CAGR of 4.49% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights. Still’s disease is a rare systemic inflammatory condition classified under polygenic autoinflammatory disorder. The condition is characterized by persistent high spiking fever, salmon colored skin rash, and arthralgia. Still’s disease is more commonly observed in infants, known as systemic-onset juvenile idiopathic arthritis (SOJIA) whereas, in adults, it is referred to as adult-onset Still’s disease (AOSD). However, there is no single diagnostic test available for Still’s disease. Diagnosis is typically done based on the observation of aforementioned symptoms. Also, the treatment option for this condition is selected based on the varying degree of symptoms. Players in the market are focused on research & development, drug approvals, and launching them in the market, which is driving growth of the still’s disease treatment market. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/stills- disease-treatment-market-4023 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Similarly, in April 2018, Swedish Orphan Biovitrum AB received expanded approval from the European Commission (EC) for Kineret (anakinra), which is an interleukin-1 receptor antagonist for the treatment of Still’s Disease. Kineret was previously approved for rheumatoid arthritis treatment. This approval expanded indication of anakinra as well as addresses the significant unmet medical need among Still’s disease patient population. Such factors are expected to strongly support growth of the still’s disease treatment market. Still’s Disease Treatment Market - Impact of Coronavirus (Covid-19) Pandemic The COVID-19 outbreak has adversely affected the still’s disease treatment market growth. It has become difficult for the researchers to conduct researches during this COVID-19 pandemic. People with Still's disease are at more risk to get infected with the COVID-19 virus. Therefore, key players in this industry are focusing on developing strategies to help patients to remain agile during the global disruptions due to the pandemic crisis. Moreover, the government bodies of various countries are taking initiatives to deal with the current chaos. Browse 26 Market Data Tables and 28 Figures spread through 140 Pages and in-depth TOC on Still’s Disease Treatment Market, By Treatment (Pain Management, Corticosteroids, Tocilizumab, Canakinumab, Anakinra, and Others), By Route of Administration (Injectable and Oral), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Forecast to 2027" Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/4023 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION The rise in funding for research & development to develop novel treatment and therapies is a major factor propelling growth of the global still’s disease treatment market. Moreover, the emergence of drugs for the complications related to adult-onset still’s disease treatment is another factor boosting the market growth. For instance, in June 2020, the U.S. Food and Drug Administration (FDA) approved the usage of Canakinumab (Ilaris) in active still’s disease. Key Takeaways of the Global Still’s Disease Treatment Market: The global still’s disease treatment market is expected to exhibit a CAGR of 4.49% during the forecast period (2020-2027), owing to collaborations and drug launches by market players Among therapy types, corticosteroid segment accounted for significant revenue share in the global market. Corticosteroid therapy is started promptly with the dosage of 0.5–1 mg/kg/day, once the diagnosis is confirmed. Major players operating in the global still’s disease treatment market include AB2 Bio Ltd., Jubilant Life Sciences Ltd, F. Hoffmann-La Roche Ltd, Swedish Orphan Biovitrum AB, Novartis AG, Vintage Labs, Teva Pharmaceutical Industries Ltd, Hikma Pharmaceuticals PLC, Mylan N.V., Sun Pharmaceutical Industries Ltd, Horizon Therapeutics plc, Zydus Cadila, Dr Reddy's Laboratories Ltd., Amneal Pharmaceuticals LLC, and Fresenius Kabi AG. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4023 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved